Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2008-07-01
2008-07-01
Foley, Shanon A. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S253100, C424S190100, C424S254100, C424S257100
Reexamination Certificate
active
10953979
ABSTRACT:
The invention relates to adjuvants that contain a lecithin, an oil and an amphiphilic surfactant and that are capable of forming a stable oil-in-water emulsion vaccine so as to minimize local reactions to the vaccine in the injected animal.
REFERENCES:
patent: 4070454 (1978-01-01), Relyveld
patent: 4237115 (1980-12-01), Brinton
patent: 4261925 (1981-04-01), Tomalia et al.
patent: 4504275 (1985-03-01), Baker
patent: 4606918 (1986-08-01), Allison et al.
patent: 4789544 (1988-12-01), Nelson et al.
patent: 4888169 (1989-12-01), Brown et al.
patent: 4933179 (1990-06-01), Allison et al.
patent: 5019388 (1991-05-01), Brown et al.
patent: 5069901 (1991-12-01), Jones et al.
patent: 5084269 (1992-01-01), Kullenberg
patent: 5209929 (1993-05-01), McGuire et al.
patent: 5242686 (1993-09-01), Chu et al.
patent: 5338543 (1994-08-01), Fitzgerald et al.
patent: 5338748 (1994-08-01), Wachman et al.
patent: 5422277 (1995-06-01), Connelly et al.
patent: 5424323 (1995-06-01), Wachman et al.
patent: 5536496 (1996-07-01), Frantz et al.
patent: 5538733 (1996-07-01), Emery et al.
patent: 5578308 (1996-11-01), Capiau et al.
patent: 5597602 (1997-01-01), Peter et al.
patent: 5603951 (1997-02-01), Woo
patent: 5612042 (1997-03-01), Jacobs
patent: 5616328 (1997-04-01), Roberts et al.
patent: 5625038 (1997-04-01), Henderson et al.
patent: 5656289 (1997-08-01), Cho et al.
patent: 5665363 (1997-09-01), Hansen et al.
patent: 5679353 (1997-10-01), Hall et al.
patent: 5690942 (1997-11-01), Hjorth
patent: 5695769 (1997-12-01), Frantz et al.
patent: 5718904 (1998-02-01), Hjorth
patent: 5814321 (1998-09-01), Miyahara et al.
patent: 5877298 (1999-03-01), Fahim et al.
patent: 5888513 (1999-03-01), Plana Duran et al.
patent: 5925359 (1999-07-01), Van Woensel et al.
patent: 5968525 (1999-10-01), Fitzgerald et al.
patent: 6013266 (2000-01-01), Segers et al.
patent: 6124432 (2000-09-01), Kawai et al.
patent: 6517843 (2003-02-01), Ellis et al.
patent: 6572861 (2003-06-01), Roberts et al.
patent: 6585981 (2003-07-01), Pijoan
patent: 6733754 (2004-05-01), Roberts et al.
patent: 6814971 (2004-11-01), Roberts et al.
patent: 2816942 (1978-04-01), None
patent: 3517805 (1985-05-01), None
patent: 0597852 (1991-12-01), None
patent: 000515415 (1995-10-01), None
patent: 91/12020 (1991-08-01), None
patent: 9112020 (1991-08-01), None
patent: WO98/15287 (1998-04-01), None
Brandenburg, AC, Canadian Journal of Comp. Med. vol. 42, pp. 23-28, 1978, Bordetella Rhinitis in pig: Serum and Nasal antibody response to Bordetella bacterins.
Sakano, Tetsuya et al, j. Vet. Med.Sci, vol. 59(10, pp. 55-57, 1997, Effect ofBordetella bronchisepticaand serotype DPasteurella multocidabacterin toxoid on teh occurrence of atrophic rhinitis after experimental infection withB. bronchisepticaand.
Goodnow, RA et al, Veterinary Medicine, Sep. 1978, pp. 1187-1188, vol. 73(9), Effect of immunization withBordetella bronchisepticabacterin on weight gain in weaning pigs.
Boslego, JW., Vaccines & Immunology Therapy, 1991, p. 211-223, Pergamon Press.
Bricker, JM et al., Avian diseases, Oct.-Dec. 1988, vol. 32(4), pp. 668-673, (abstract only).
Chen, C et al., Journal of the Chinese Society of Veterinary Science, vol. 21(4), pp. 212-222, 1995 (abstract only).
Davis et al (1974) Retention of Significant Antibody binding by Surface Antigens of Feline Leukemia Cells (FLA) After Fixation with Formaldehyde and Glutaraldehyde, Immunol. Comun. vol. 3(2), pp. 189-197.
Ellis, RW, Vaccines, Chapter 29, p. 568-575, 1988, Plotkin & Mortmer.
Kreutz, LC, “Cellular membrane factors are the major determinants of porcine reproductive and respiratory syndrome virus tropism,” Virus Research 53:121-128, 1998.
Kume, K et al. Infection and Immunity, Properties of dermonecrotic toxin prepared from sonic extractsBordetella bronchiseptica, May 1986, vol. 52(2), pp. 370-377 (abstract only).
Maniatis et al., 1989 Molecular Cloning, A Laboratory Manual, Cold Springs Harbor Laboratory Press, Cold Springs Harbor, NY.
Markowska-Daniel, I et al., Zentralbatt fur Bakteriologie, vol. 277(4), pp. 547-553, 1992 (abstract only).
RespiSure Package Insert, Jan. 17, 1999.
Vogel and Powell, A Compendium of Vaccine Adjuvants and Excipients, Chapter 7, pp. 141-228.
Dearwester Don A.
Roberts David S.
Swearingin Leroy A.
Foley Shanon A.
Gumbleton Timothy J.
Pfizer Inc.
Portner Ginny
Wootton Thomas A.
LandOfFree
Adjuvants for use in vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adjuvants for use in vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adjuvants for use in vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3913944